Patents Represented by Attorney, Agent or Law Firm Millen White Zelano & Branigan
  • Method for cooling superconducting magnets
    Patent number: 8291725
    Abstract: The invention describes a method for cooling at least one super-conducting magnet. According to the invention, the cooling of the super-conducting magnet(s) takes place exclusively by means of one or more helium flows which are at at least two temperature levels.
    Type: Grant
    Filed: October 31, 2007
    Date of Patent: October 23, 2012
    Assignee: Linde Aktiengesellschaft
    Inventor: Andres Kundig
  • Birefringent polymer film with negative optical dispersion
    Patent number: 8289494
    Abstract: The invention relates to a polymer film having negative optical dispersion, novel polymerisable compounds and liquid crystal (LC) materials for its preparation, and the use of the polymer film and novel compounds and materials in optical, electrooptical, electronic, semiconducting or luminescent components or devices.
    Type: Grant
    Filed: March 4, 2008
    Date of Patent: October 16, 2012
    Assignee: Merck Patent GmbH
    Inventors: Owain Llyr Parri, Kevin Adlem, Karl Skjonnemand, David Wilkes
  • Biaxial film II
    Patent number: 8287756
    Abstract: The invention relates to an optically biaxial film comprising an anisotropic material with uniform helically twisted structure and a reflection wavelength below 400 nm, to methods and materials for its preparation, to its use as retardation or compensation film in optical devices like liquid crystal displays, and to compensators and liquid crystal displays comprising such a biaxial film.
    Type: Grant
    Filed: June 15, 2005
    Date of Patent: October 16, 2012
    Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
    Inventors: Mark Verrall, Kim Slaney, Owain Llyr Parri, Richard Harding, Shirley Ann Marden
  • Method of converting feedstocks from renewable sources to good-quality diesel fuel bases using a zeolite catalyst without intermediate gas-liquid separation
    Patent number: 8282815
    Abstract: The invention relates to a method of treating feedstocks from renewable sources without intermediate gas-liquid separation in order to produce diesel fuel bases of excellent quality. The feedstocks used can be raw vegetable oils or such oils that have been previously subjected to a prerefining stage, animal fats, or mixtures of such feedstocks. The invention relates to a method allowing high diesel fuel base yields to be obtained from such feedstocks.
    Type: Grant
    Filed: June 24, 2009
    Date of Patent: October 9, 2012
    Assignee: IFP Energies nouvelles
    Inventors: Christophe Bouchy, Antoíne Daudin, Emmanuelle Guillon, Nathalie Dupassieux, Thierry Chapus
  • Pharmaceutical composition for topical application of poorly soluble compounds
    Patent number: 8282909
    Abstract: The present invention provides a formulation which contains a poorly water soluble pharmaceutically active compound at a concentration of 50 mg per 100 g formulation or above. The solubility is achieved by a mixture of solvents as described herein. Moreover the formulation as described herein may be used as a base formulation to generate a cream, an ointment, a spray, a foam or an oleogel.
    Type: Grant
    Filed: July 9, 2008
    Date of Patent: October 9, 2012
    Assignee: Intendis GmbH
    Inventors: Hartwig Steckel, Karin Hoffmann
  • Reforming catalyst preparation by dry impregnation
    Patent number: 8283280
    Abstract: The invention relates to a method of preparing a reforming catalyst comprising a group VIII metal, a halogen, at least one metal selected from the group made up of the group VIIB metals and group IVA metals, a refractory oxide support. The method comprises stages of preparing a dry impregnation aqueous solution containing ammonia, either in solution or in gas form and a complexing agent, of aging the aqueous solution, of dry impregnation of the support, of maturing the impregnated support, of drying and of calcination.
    Type: Grant
    Filed: May 5, 2010
    Date of Patent: October 9, 2012
    Assignee: IFP Energies nouvelles
    Inventor: Yohan Oudart
  • Use of phosphinic acids and/or phosphonic acids in redox processes
    Patent number: 8282808
    Abstract: The present invention relates to the use of phosphinic acids and/or phosphonic acids and salts thereof, preferably as surface-active compounds, in redox processes, in particular in electroplating technology, particularly preferably in electroplating baths, and to electroplating baths comprising these compounds.
    Type: Grant
    Filed: May 4, 2007
    Date of Patent: October 9, 2012
    Assignee: Merck Patent GmbH
    Inventors: Wolfgang Hierse, Nikolai Ignatyev
  • Imidazo 1,2-pyrimidine derivatives for the treatment of diseases such as diabetes
    Patent number: 8278312
    Abstract: Novel compounds of the formula (I), in which W, T, R1, R2, R3, R4, R5, R6 and X7 have the meanings indicated in Patent Claim 1, are suitable as antidiabetics.
    Type: Grant
    Filed: September 13, 2008
    Date of Patent: October 2, 2012
    Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
    Inventors: Markus Klein, Werner Mederski, Christos Tsaklakidis, Norbert Beier
  • Method for optimizing the operation of a unit for the synthesis of hydrocarbons from a synthesis gas
    Patent number: 8278364
    Abstract: The invention concerns a method for optimizing the operation of a reaction section for hydrocarbon synthesis starting from a feed comprising synthesis gas, operated in the presence of a catalyst comprising cobalt. This method comprises the following steps: a) determining the theoretical molar ratio, PH2O:PH2, in the reaction section; b) optionally, adjusting the ratio PH2O:PH2 determined in step a) to a value strictly below 1; c) determining the new value for the theoretical ratio PH2O:PH2 in the reaction section; and repeating steps a) to c) until the ratio of the partial pressures of water and hydrogen, PH2O:PH2, has a value strictly less than 1.1.
    Type: Grant
    Filed: November 2, 2007
    Date of Patent: October 2, 2012
    Assignee: IFP Energies nouvelles
    Inventors: Marie-Claire Marion, Francois Hugues
  • Recombinant platelet collagen receptor glycoprotein VI and its pharmaceutical use
    Patent number: 8278430
    Abstract: The invention relates to Glycoprotein VI (GPVI), its isolation, purification, and methods for recombinant production. Especially, the invention relates to the use of GPVI, preferably recombinant GPVI, in the treatment of disorders and pathological events correlated directly or indirectly to blood coagulation disorders such as thrombotic and cardiovascular diseases. The extracellular recombinant protein can also be used for establishing screening assays to find potential inhibitors of the membrane bound GPVI in order to inhibit binding of thrombocytes and platelets, respectively, to collagen. Changes in GPVI can be used to monitor platelet age and exposure to thrombotic and cardiovascular diseases.
    Type: Grant
    Filed: March 11, 2011
    Date of Patent: October 2, 2012
    Assignee: Aventis Pharma Deutschland, GmbH
    Inventor: Kenneth J. Clemeston
  • Liquid-crystal medium
    Patent number: 8277684
    Abstract: The invention relates to a liquid-crystalline medium of negative dielectric anisotropy based on a mixture of polar compounds, which comprises at least one compound selected from the group of the compounds of the formulae IA, IB and IC in which R1A, R2A, R1B, R2B, R1C, R2C, L, m, n, o, p and b have the meanings indicated in Claim 1, and to the use thereof for an active-matrix display, in particular based on the ECB, PALC, FFS or IPS effect.
    Type: Grant
    Filed: August 7, 2008
    Date of Patent: October 2, 2012
    Assignee: Merck Patent Gesellschaft mit beschrankter Haftung
    Inventors: Melanie Klasen-Memmer, Matthias Bremer, Kazuaki Tarumi
  • Liquid-crystalline medium
    Patent number: 8277907
    Abstract: The present invention relates to a liquid-crystalline medium based on a mixture of polar compounds having negative dielectric anisotropy (??), which is distinguished by the fact that it has a value for the ratio ?1/?n2 in the range 6-45 with a clearing point of >60° C. and a ?? of ??2.3. Media of this type are particularly suitable for electro-optical displays having active-matrix addressing based on the ECB, PA LCD, FFS or IPS effect.
    Type: Grant
    Filed: June 28, 2011
    Date of Patent: October 2, 2012
    Assignee: Merck Patent GmbH
    Inventors: Melanie Klasen-Memmer, Sabine Schoen
  • Indenofluorene polymer based organic semiconductor materials
    Patent number: 8278394
    Abstract: The invention relates to polymers comprising indenofluorene units or derivatives thereof, organic semiconductor (OSC) materials comprising them, their use in electronic or electrooptical devices, and devices comprising said polymers or materials.
    Type: Grant
    Filed: April 13, 2007
    Date of Patent: October 2, 2012
    Assignee: Merck Patent Gesellschaft mit Beschränkter Haftung
    Inventors: Junyou Pan, Susanne Heun, Frank Meyer
  • Process for preparing tetrahydroquinoline derivatives
    Patent number: 8278454
    Abstract: The invention relates to a novel process for preparing enantiomerically enriched or pure tetrahydroquinoline derivatives by reacting a chiral dihydropyran-methylamine C with a aldehyde B and an aniline A in a multicomponent one pot synthesis in the presence of a protonic acid or lewis acid with a suitable solvent. A, B, C have the meaning as described in the specification.
    Type: Grant
    Filed: November 20, 2008
    Date of Patent: October 2, 2012
    Assignee: Merck Patent Gesellschaft mit beschränkter Haftung
    Inventors: Ulrich Emde, Oliver Block, Kai Schiemann
  • 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
    Patent number: 8278469
    Abstract: The invention relates to 17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives of Formula I with progesterone antagonizing action and method of production thereof, use thereof for the treatment and/or prophylaxis of diseases and use thereof for the production of medicinal products for the treatment and/or prophylaxis of diseases, in particular of fibroids of the uterus (myomas, uterine leiomyoma), endometriosis, heavy menstrual bleeds, meningiomas, hormone-dependent breast cancers and complaints associated with the menopause or for fertility control and emergency contraception.
    Type: Grant
    Filed: December 13, 2011
    Date of Patent: October 2, 2012
    Assignee: Bayer Pharma Aktiengesellschaft
    Inventors: Wolfgang Schwede, Ulrich Klar, Carsten Moller, Andrea Rotgeri, Wilhelm Bone
  • Process for desulfurization and denitration of a gas-oil-type hydrocarbon fraction that contains nitrogen compounds
    Patent number: 8273243
    Abstract: The invention describes an improved process for deep desulfurization of a gas-oil-type hydrocarbon fraction that comprises a catalytic hydrodesulfurization unit that is preceded by a unit for adsorption of the nitrogen compounds that inhibit the hydrodesulfurization reaction.
    Type: Grant
    Filed: February 14, 2008
    Date of Patent: September 25, 2012
    Assignee: IFP Energies nouvelles
    Inventors: Alexandre Nicolaos, Patrick Briot, Danielle Richard
  • Ribbon flag
    Patent number: D668991
    Type: Grant
    Filed: February 9, 2012
    Date of Patent: October 16, 2012
    Inventors: Madelyn Sussman, Barbara Sussman
  • Ribbon flag
    Patent number: D668992
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: October 16, 2012
    Inventors: Madelyn Sussman, Barbara Sussman
  • Ribbon flag
    Patent number: D668993
    Type: Grant
    Filed: January 18, 2012
    Date of Patent: October 16, 2012
    Inventors: Madelyn Sussman, Barbara Sussman
  • Ring of dosimetry
    Patent number: D669373
    Type: Grant
    Filed: December 23, 2010
    Date of Patent: October 23, 2012
    Assignee: Institut de Radioprotection et de Nucleaire
    Inventors: Sophie Genet-Jegard, Alexandre Hoflak, Patrice Fraboulet